Cowen And Company, LLC Agios Pharmaceuticals, Inc. Put Options Transaction History

Cowen And Company, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$26.68 - $34.81 $266,800 - $348,100	10,000 Added 50.0%	30,000 $500,000
Q4 2021 Feb 14, 2022	BUY	$29.58 - $49.78 $591,600 - $995,600	20,000 New	20,000 $26,000
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $2.87 Million - $3.98 Million	-68,400 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$52.06 - $61.27 $2.29 Million - $2.7 Million	44,000 Added 180.33%	68,400 $68,000
Q1 2021 May 04, 2021	BUY	$44.23 - $57.5 $636,912 - $828,000	14,400 Added 144.0%	24,400 $74,000
Q4 2020 Feb 08, 2021	BUY	$33.21 - $46.54 $332,100 - $465,400	10,000 New	10,000 $26,000
Q1 2020 May 11, 2020	SELL	$31.52 - $53.81 $157,600 - $269,050	-5,000 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$30.08 - $50.59 $1.09 Million - $1.83 Million	-36,200 Reduced 87.86%	5,000 $1,000
Q3 2019 Nov 12, 2019	BUY	$32.4 - $49.58 $1.33 Million - $2.04 Million	41,200 New	41,200 $140,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.05B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.